Wang, D. & Gao, G. State-of-the-art human gene therapy: part II. Gene therapy strategies and clinical applications. Discov. Med. 18, 151–161 (2014).

PubMed  PubMed Central  Google Scholar 

Adams, D. et al. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N. Engl. J. Med. 379, 11–21 (2018).

Article  CAS  PubMed  Google Scholar 

Wang, J. et al. AAV-delivered suppressor tRNA overcomes a nonsense mutation in mice. Nature 604, 343–348 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang, D. & Gao, G. State-of-the-art human gene therapy: part I. Gene delivery technologies. Discov. Med. 18, 67–77 (2014).

PubMed  PubMed Central  Google Scholar 

Bulcha, J. T., Wang, Y., Ma, H., Tai, P. W. L. & Gao, G. Viral vector platforms within the gene therapy landscape. Sig. Transduct. Target. Ther. 6, 53 (2021).

Article  CAS  Google Scholar 

Atchison, R. W., Casto, B. C. & Hammon, W. M. Adenovirus-associated defective virus particles. Science 149, 754–756 (1965).

Article  CAS  PubMed  Google Scholar 

Hoggan, M. D., Blacklow, N. R. & Rowe, W. P. Studies of small DNA viruses found in various adenovirus preparations: physical, biological, and immunological characteristics. Proc. Natl Acad. Sci. 55, 1467–1474 (1966).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Samulski, R. J., Berns, K. I., Tan, M. & Muzyczka, N. Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells. Proc. Natl Acad. Sci. 79, 2077–2081 (1982).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Laughlin, C. A., Tratschin, J. D., Coon, H. & Carter, B. J. Cloning of infectious adeno-associated virus genomes in bacterial plasmids. Gene 23, 65–73 (1983).

Article  CAS  PubMed  Google Scholar 

Srivastava, A., Lusby, E. W. & Berns, K. I. Nucleotide sequence and organization of the adeno-associated virus 2 genome. J. Virol. 45, 555–564 (1983).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Samulski, R. J., Chang, L. S. & Shenk, T. A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. J. Virol. 61, 3096–3101 (1987).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao, G. P. et al. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl Acad. Sci. 99, 11854–11859 (2002).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao, G. et al. Clades of Adeno-associated viruses are widely disseminated in human tissues. J. Virol. 78, 6381–6388 (2004).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheung, A. K., Hoggan, M. D., Hauswirth, W. W. & Berns, K. I. Integration of the adeno-associated virus genome into cellular DNA in latently infected human Detroit 6 cells. J. Virol. 33, 739–748 (1980).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Laughlin, C. A., Cardellichio, C. B. & Coon, H. C. Latent infection of KB cells with adeno-associated virus type 2. J. Virol. 60, 515–524 (1986).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang, D., Tai, P. W. L. & Gao, G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat. Rev. Drug Discov. 18, 358–378 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dunbar, C. E. et al. Gene therapy comes of age. Science 359, eaan4672 (2018).

Article  PubMed  Google Scholar 

Keeler, A. M. & Flotte, T. R. Recombinant adeno-associated virus gene therapy in light of luxturna (and Zolgensma and Glybera): where are we, and how did we get here? Annu. Rev. Virol. 6, 601–621 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang, D., Zhang, F. & Gao, G. CRISPR-based therapeutic genome editing: strategies and in vivo delivery by AAV vectors. Cell 181, 136–150 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li, C. & Samulski, R. J. Engineering adeno-associated virus vectors for gene therapy. Nat. Rev. Genet. 21, 255–272 (2020).

Article  CAS  PubMed  Google Scholar 

Tseng, Y. S. & Agbandje-McKenna, M. Mapping the AAV capsid host antibody response toward the development of second generation gene delivery vectors. Front. Immunol. 5, 9 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Sonntag, F., Schmidt, K. & Kleinschmidt, J. A. A viral assembly factor promotes AAV2 capsid formation in the nucleolus. Proc. Natl Acad. Sci. 107, 10220–10225 (2010).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kelsic, E. D., Ogden, P. J., Sinai, S. & Church, G. M. Comprehensive AAV capsid fitness landscape reveals a viral gene and enables machine-guided design. Science 366, 1139–1143 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Lusby, E., Fife, K. H. & Berns, K. I. Nucleotide sequence of the inverted terminal repetition in adeno-associated virus DNA. J. Virol. 34, 402–409 (1980).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao, G. et al. Adeno-associated viruses undergo substantial evolution in primates during natural infections. Proc. Natl Acad. Sci. 100, 6081–6086 (2003).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Calcedo, R., Vandenberghe, L. H., Gao, G., Lin, J. & Wilson, J. M. Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses. J. Infect. Dis. 199, 381–390 (2009).

Article  PubMed  Google Scholar 

Bashirians, G. et al. Global seroprevalence of neutralizing antibodies against adeno-associated virus (AAV) serotypes of relevance to gene therapy. Blood 140, 10668–10670 (2022).

Article  Google Scholar 

Matsushita, T. et al. Adeno-associated virus vectors can be efficiently produced without helper virus. Gene Ther. 5, 938–945 (1998).

Article  CAS  PubMed  Google Scholar 

Xiao, X., Li, J. & Samulski, R. J. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. 72, 2224–2232 (1998).

Article  CAS  PubMed  PubMed Central  Google Scholar 

McCarty, D. M. Jr., Young, S. M. & Samulski, R. J. Integration of adeno-associated viruS (AAV) and recombinant AAV vectors. Annu. Rev. Genet. 38, 819–845 (2004).

Article  CAS  PubMed  Google Scholar 

Servellita, V. et al. Adeno-associated virus type 2 in US children with acute severe hepatitis. Nature 617, 1–7 (2023).

Article  Google Scholar 

Morfopoulou, S. et al. Genomic investigations of unexplained acute hepatitis in children. Nature 617, 564–573 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ho, A. et al. Adeno-associated virus 2 infection in children with non-A–E hepatitis. Nature 617, 555–563 (2023).

Article  CAS  PubMed  Google Scholar 

Tacke, F. Severe hepatitis outbreak in children linked to AAV2 virus. Nature 617, 471–472 (2023).

Article  CAS  PubMed  Google Scholar 

Lisowski, L., Tay, S. S. & Alexander, I. E. Adeno-associated virus serotypes for gene therapeutics. Curr. Opin. Pharmacol. 24, 59–67 (2015).

Article  CAS  PubMed  Google Scholar 

Issa, S. S., Shaimardanova, A. A., Solovyeva, V. V. & Rizvanov, A. A. Various AAV Serotypes and their applications in gene therapy: an overview. Cells 12, 785 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Verdera, H. C., Kuranda, K. & Mingozzi, F. AAV vector immunogenicity in humans: a long journey to successful gene transfer. Mol. Ther. 28, 723–746 (2020).

Article